Arakawa I - Search Results

1

Cost-effectiveness of aprepitant in Japanese patients treated with cisplatin-containing highly emetogenic chemotherapy.

Tsukiyama I, Hasegawa S, Ikeda Y, Takeuchi M, Tsukiyama S, Kurose Y, Ejiri M, Sakuma M, Saito H, Arakawa I, Inoue T, Yamaguchi E, Kubo A. Tsukiyama I, et al. Among authors: arakawa i. Cancer Sci. 2018 Sep;109(9):2881-2888. doi: 10.1111/cas.13736. Epub 2018 Aug 3. Cancer Sci. 2018. PMID: 29999572 Free PMC article. Clinical Trial.

2

A Cost-Effectiveness Analysis of Gemcitabine plus Cisplatin Versus Gemcitabine Alone for Treatment of Advanced Biliary Tract Cancer in Japan.

Tsukiyama I, Ejiri M, Yamamoto Y, Nakao H, Yoneda M, Matsuura K, Arakawa I, Saito H, Inoue T. Tsukiyama I, et al. Among authors: arakawa i. J Gastrointest Cancer. 2017 Dec;48(4):326-332. doi: 10.1007/s12029-016-9885-6. J Gastrointest Cancer. 2017. PMID: 27785685 Free PMC article.

3

Cost-utility analysis of aprepitant for patients who truly need it in Japan.

Tsukiyama I, Ando M, Tsukiyama S, Takeuchi M, Ejiri M, Kurose Y, Saito H, Arakawa I, Inoue T, Yamaguchi E, Kubo A. Tsukiyama I, et al. Among authors: arakawa i. Support Care Cancer. 2019 Oct;27(10):3749-3758. doi: 10.1007/s00520-019-04672-w. Epub 2019 Feb 1. Support Care Cancer. 2019. PMID: 30710243

4

Adjuvant endocrine therapy in post menopausal women: pharmacological evaluation using decision analysis approach in a Japanese hospital setting.

Miyazaki Y, Arakawa I, Inoue T. Miyazaki Y, et al. Among authors: arakawa i. Gan To Kagaku Ryoho. 2009 Aug;36(8):1299-309. Gan To Kagaku Ryoho. 2009. PMID: 19692769

5

[Comparison of the Cost-Effectiveness of the SOX and COX Regimens in Patients with Unresectable Advanced and Recurrent Colorectal Cancer Using a Clinical Decision Analysis Approach].

Nagase S, Iyoda T, Kanno H, Akase T, Arakawa I, Inoue T, Uetsuka Y. Nagase S, et al. Among authors: arakawa i. Gan To Kagaku Ryoho. 2016 Oct;43(10):1201-1205. Gan To Kagaku Ryoho. 2016. PMID: 27760938 Japanese.

6

Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan.

Miyazaki Y, Harada T, Akase T, Arakawa I, Inoue T. Miyazaki Y, et al. Among authors: arakawa i. Clin Ther. 2009;31 Pt 2:2433-41. doi: 10.1016/j.clinthera.2009.11.014. Clin Ther. 2009. PMID: 20110051

7

[Cost-effectiveness of salmeterol/fluticasone combination therapy vs. fluticasone propionate in Japanese asthmatic patients].

Tohda Y, Nishima S, Arakawa I, Shiragami M, Miyamoto T. Tohda Y, et al. Among authors: arakawa i. Yakugaku Zasshi. 2010 Apr;130(4):593-603. doi: 10.1248/yakushi.130.593. Yakugaku Zasshi. 2010. PMID: 20372007 Free article. Japanese.

8

Cost-effectiveness analysis of dupilumab among patients with oral corticosteroid-dependent uncontrolled severe asthma in Japan.

Tohda Y, Matsumoto H, Miyata M, Taguchi Y, Ueyama M, Joulain F, Arakawa I. Tohda Y, et al. Among authors: arakawa i. J Asthma. 2022 Nov;59(11):2162-2173. doi: 10.1080/02770903.2021.1996596. Epub 2021 Dec 8. J Asthma. 2022. PMID: 34752208

9

Regarding 'HPV vaccination for cervical cancer prevention is not cost-effective in Japan'.

Arakawa I, Murasawa H, Konno R. Arakawa I, et al. Asian Pac J Cancer Prev. 2015;16(6):2583-4. doi: 10.7314/apjcp.2015.16.6.2583. Asian Pac J Cancer Prev. 2015. PMID: 25824801 Free article. No abstract available.

10

Cost-effectiveness of the recommended medical intervention for the treatment of dysmenorrhea and endometriosis in Japan.

Arakawa I, Momoeda M, Osuga Y, Ota I, Koga K. Arakawa I, et al. Cost Eff Resour Alloc. 2018 Apr 10;16:12. doi: 10.1186/s12962-018-0097-8. eCollection 2018. Cost Eff Resour Alloc. 2018. PMID: 29643744 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters